Daniel Chapter One v. Federal Trade Commission
405 F. App'x 505
D.C. Cir.2010Background
- Daniel Chapter One and James Feijo petition FTC order denying relief; proceeding considered on record, briefs, and arguments.
- DCO argues its status as a Washington religious corporation sole immunizes it from FTC regulation of advertisements.
- FTC alleges DCO’s dietary supplement ads are deceptive due to lack of a reasonable basis for claims.
- Court applies the reasonable-basis standard requiring competent and reliable scientific evidence, including human clinical trials.
- FTC guidance and expert testimony indicate the required substantiation; appearance of consumer messages was considered.
- DCO pursues constitutional RFRA and Establishment Clause defenses, which court rejects.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Jurisdiction over DCO | DCO contends status as a corporate sole bars FTC regulation. | Court should ignore corporate form and assess substance of DCO’s for-profit activity. | FTC has jurisdiction; substance shows for-profit economic benefits. |
| Reasonable basis for claims | DCO argues no basis required beyond general claims. | FTC requires competent and reliable scientific evidence, including clinical trials. | FTC validly requires competent evidence; lack of reliable scientific basis makes ads deceptive. |
| Constitutional RFRA and Establishment Clause defenses | RFRA and Establishment Clause protect religious communications and practices. | Deceptive commercial speech receives no First Amendment protection; RFRA/Establishment claims lack merit. | Claims meritless; regulation upheld as narrowly tailored to prevent deception. |
Key Cases Cited
- Cal. Dental Ass’n v. FTC, 526 U.S. 756 (U.S. 1999) (jurisdiction focused on substance of activity rather than form)
- Cmty. Blood Bank v. FTC, 405 F.2d 1011 (8th Cir.1969) (court-approved approach to jurisdiction over organizational conduct)
- Thompson Med. Co., Inc. v. FTC, 791 F.2d 189 (D.C. Cir.1986) (reasonable-basis standard for advertising claims)
- In re Pfizer, Inc., 81 F.T.C. 23 (1972) (FTC precedents guiding substantiation of claims)
- Central Hudson Gas & Elec. Corp. v. Pub. Serv. Comm’n, 447 U.S. 557 (U.S. 1980) (framework for evaluating truthful commercial speech regulation)
- Novartis Corp. v. FTC, 223 F.3d 783 (D.C. Cir. 2000) (affirmed FTC’s authority to regulate deceptive advertising)
- Peloza v. Capistrano Unified Sch. Dist., 37 F.3d 517 (9th Cir.1994) (religion-related holdings relevant to RFRA arguments)